Abstract
Statistical experimental designs such as factorial, optimal, or definitive screening designs represent the state of the art in biopharmaceutical process characterization. However, such methods alone do not leverage the fact that processes operate as a mutual interplay of multiple steps. Instead, they aim to investigate only one process step at a time. Here, we want to develop a new experimental design method that seeks to gain information about final product quality, placing the right type of run at the right unit operation. This is done by minimizing the simulated out-of-specification rate of an integrated process model comprised of a chain of regression models that map process parameters to critical quality attributes for each unit operation. Unit operation models are connected by passing their response to the next unit operation model as a load parameter, as is done in real-world manufacturing processes. The proposed holistic DoE (hDoE) method is benchmarked against standard process characterization approaches in a set of in silico simulation studies where data are generated by different ground truth processes to illustrate the validity over a range of scenarios. Results show that the hDoE approach leads to a >50% decrease in experiments, even for simple cases, and, at the same time, achieves the main goal of process development, validation, and manufacturing to consistently deliver product quality.
Funder
Austrian Research Promotion Agency
Reference30 articles.
1. ICH Guideline Q8 (R2) on Pharmaceutical Development, 2017.
2. Burdick, R., LeBlond, D., Pfahler, L., Quiroz, J., Sidor, L., Vukovinsky, K., and Zhang, L. Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry, 2017.
3. Process Validation: General Principles and Practices, 2011.
4. Montgomery, D.C., Peck, E.A., and Vining, G.G. Introduction to Linear Regression Analysis, 2021.
5. Montgomery, D.C. Design and Analysis of Experiments, 2017.